Clinical Trial Update: Immunogenicity of RSV Vaccines in Residents of Long-Term Care Facilities (LTCF) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing the immunogenicity of respiratory syncytial virus vaccines in residents of long-term care facilities; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Drugs mentioned

• RSV vaccine (investigational)

Snippet

Sponsor: University of Rochester | Conditions: Respiratory Syncytial Virus (RSV) | Phase 4 | Status: COMPLETED | Results posted: 2025-10-27